Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic

S Larisch-Bloch1, D Danielpour, N S Roche

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892-5055, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|February 15, 2000
PubMed

Insights

Researchers identified a novel protein, ARTS, involved in regulating cell death pathways. This discovery offers a new model for studying apoptosis and its relation to cancer cell growth resistance.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGF-beta) typically induces cell death in prostate carcinoma cells.
  • Understanding the molecular mechanisms of TGF-beta resistance is crucial for cancer therapy.

Purpose of the Study:

  • To identify genetic mutations conferring resistance to TGF-beta-induced apoptosis in NRP-154 rat prostate carcinoma cells.
  • To characterize the molecular players involved in TGF-beta signaling and apoptosis resistance.

Main Methods:

  • Retroviral insertional mutagenesis to generate resistant cell lines.
  • Analysis of TGF-beta receptor expression and signaling.
  • Cloning and characterization of novel genes, including ARTS.
  • Assessment of apoptosis and cell growth indicators.

Main Results:

  • A mutant clone, M-NRP1, exhibited resistance to TGF-beta-induced cell death but retained TGF-beta receptor expression and responsiveness to other apoptotic stimuli.
  • M-NRP1 cells overexpressed the antiapoptotic protein Bcl-xL.
  • A novel human septin-related protein, ARTS (apoptotic response to TGF-beta signals), was identified and found to be dysregulated in M-NRP1 cells.
  • ARTS expression was linked to TGF-beta-induced apoptosis competency.

Conclusions:

  • M-NRP1 cells provide a valuable model for studying TGF-beta-mediated apoptosis pathways.
  • The novel protein ARTS may function in conjunction with Bcl-xL within the same apoptotic pathway.
  • Dysregulation of ARTS and Bcl-xL contributes to TGF-beta resistance in prostate carcinoma cells.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...